5 Key Takeaways

• 1

  Off-label treatments can provide hope for patients with complex or refractory ocular conditions when standard therapies fail.

• 2

  Meticulous documentation is essential when prescribing off-label to protect both patient safety and clinician liability.

• 3

  Topical insulin has shown promise in improving symptoms and ocular health in patients with dry eye disease despite prior treatments.

• 4

  Clinicians should prioritize clarity and transparency in documentation to strengthen their defense against potential legal claims.

• 5

  Regular monitoring for adverse effects is crucial when using off-label therapies, especially when the full risk profile is unknown.